
Effects of Adjunctive Aripiprazole on Sexual Functioning in Patients With Major Depressive Disorder and an Inadequate Response to Standard Antidepressant Monotherapy
Author(s) -
Maurizio Fava,
Christina Dording,
Ross A. Baker,
Raymond Mankoski,
Quynh-Van Tran,
Robert A. Forbes,
James M. Eudicone,
Randall Owen,
R. Berman
Publication year - 2011
Publication title -
primary care companion to cns disorders/the primary care companion for cns disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.328
H-Index - 50
eISSN - 2155-7772
pISSN - 2155-7780
DOI - 10.4088/pcc.10m00994gre
Subject(s) - aripiprazole , placebo , major depressive disorder , adjunctive treatment , antidepressant , medicine , population , post hoc analysis , depression (economics) , psychology , psychiatry , schizophrenia (object oriented programming) , anxiety , mood , alternative medicine , environmental health , pathology , economics , macroeconomics
To investigate the specific effect of adjunctive aripiprazole on sexual function in patients with major depressive disorder and a history of an inadequate response to antidepressant medication by controlling for improvement in depressive symptoms as measured by improvement in Montgomery-Asberg Depression Rating Scale (MADRS) total scores.